Siegfried Grafton Eyes Importing GHB and Weed Extracts
Published Date: 3/19/2026
Notice
Summary
Siegfried Grafton, Inc. wants to become an official importer of certain controlled substances, including Gamma Hydroxybutyric Acid and Marijuana Extract. People and companies involved with these drugs can share their thoughts or ask for a hearing by April 20, 2026. This move could impact how these substances enter the U.S. and might affect businesses handling them.
Analyzed Economic Effects
3 provisions identified: 1 benefits, 1 costs, 1 mixed.
Import Authorization Limited to Testing/Distribution
The applicant stated it plans to import the listed controlled substances for analytical testing or distribution only; no other activities for these drug codes are authorized for this registration. Authorization will not extend to the import of FDA-approved or non-approved finished dosage forms for commercial sale, and approvals will only be issued consistent with 21 U.S.C. 952(a)(2).
Importer Application for Schedule I Drugs
On February 25, 2026, Siegfried Grafton, Inc. applied to be registered as an importer of these Schedule I controlled substances: Gamma Hydroxybutyric Acid (code 2010), Marihuana Extract (7350), Marihuana (7360), 3,4-Methylenedioxy-xymethamphetamine (7405), and Dimethyltryptamine (7435). The application is for importation only and was submitted for review by the Drug Enforcement Administration.
Public Comment and Hearing Deadline
Registered bulk manufacturers of the affected basic class(es) and applicants may submit electronic comments or objections, or file a written request for a hearing, on or before April 20, 2026 (submit comments via https://www.regulations.gov). Hearing requests must also be mailed to DEA addresses listed in the notice.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-06523 — Designation of P2P Methyl Glycidic Acid as a List I Chemical
Starting May 4, 2026, anyone handling P2P methyl glycidic acid—a key chemical used to make illegal drugs like methamphetamine—must follow new government rules and register with the DEA. This means all transactions, big or small, will be closely watched to stop illegal drug production. Businesses dealing with this chemical should act fast to stay legal and avoid penalties.
2026-06521 — Importer of Controlled Substances Application: Lipomed/LGC Standards
Lipomed/LGC Standards wants to become an official importer of certain controlled substances, like 3-Fluoro-N-methylcathinone. This means companies involved with these drugs can comment or ask for a hearing by May 4, 2026. If approved, it could impact how these substances enter the U.S., but no direct costs are mentioned yet.
2026-06051 — Importer of Controlled Substances Application: Usona Institute
Usona Institute wants to become an official importer of some powerful controlled substances like mescaline and psilocybin. People who make or use these drugs can share their thoughts or ask for a hearing by April 29, 2026. This move could impact research and medical use, with no direct cost changes announced yet.
2026-05912 — Bulk Manufacturer of Controlled Substances Application: SpecGx LLC
SpecGx LLC wants to become a big-time maker of some powerful and tightly controlled drugs, including things like psilocybin and fentanyl. People and companies already registered can share their thoughts or ask for a hearing by May 26, 2026. This move could shake up how these substances are made and handled, so keep an eye on the deadlines if you’re involved!
2026-05618 — Schedules of Controlled Substances: Placement of 3-Methoxyphencyclidine (1-(1-(3-Methoxyphenyl)cyclohexyl)piperidine) in Schedule I
Starting April 22, 2026, the DEA is putting 3-methoxyphencyclidine (3-MeO-PCP) into Schedule I, meaning it’s now officially a highly controlled substance with strict rules. This affects anyone who makes, sells, studies, or even possesses 3-MeO-PCP, who will face serious legal consequences. This move helps the U.S. follow international drug laws and keeps communities safer.
2026-05486 — Exempt Chemical Preparations Under the Controlled Substances Act
The Drug Enforcement Administration (DEA) just updated which chemical mixes are officially exempt from strict drug rules between September 2024 and December 2025. Companies and labs using these chemicals should check the new list to see if their products are approved or denied. You’ve got until May 19, 2026, to share your thoughts, and no extra fees are involved—just a quick review and comment if you want!
Previous / Next Documents
Previous: 2026-05355 — Importer of Controlled Substances Application: Patheon API Services, Inc.
Patheon API Services, Inc. wants to become an official importer of certain controlled substances like dimethyltryptamine and psilocybin. People who make or use these drugs can share their thoughts or ask for a hearing by April 20, 2026. This move could impact companies handling these substances and might affect how these drugs enter the U.S. market.
Next: 2026-05357 — Bulk Manufacturer of Controlled Substances Application: Sterling Wisconsin, LLC
Sterling Wisconsin, LLC wants to become a big-time maker of certain controlled substances, including some strong medicines and psychedelics. People and companies who might be affected can share their thoughts or ask for a hearing by May 18, 2026. This move could shake up how these substances are made and handled, but no costs or changes to the public are expected right now.
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in